Published Online
on June 8, 2009

A more recent version of this article appeared on July 1, 2009

This Article Full Text (PDF) All Versions of this Article: 54/1/29    most recent HYPERTENSIONAHA.109.133579v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Benigni, A. Articles by Remuzzi, G. PubMed PubMed Citation Articles by Benigni, A. Articles by Remuzzi, G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Clinical Studies Related Article

Treatment of Chronic Proteinuric Kidney Disease. What Next?

Ariela Benigni^* and Giuseppe Remuzzi

From the Mario Negri Institute for Pharmacological Research (A.B., G.R.); and the Division of Nephrology and Dialysis (G.R.), Azienda Ospedaliera Ospedali Riuniti di Bergamo, Bergamo, Italy.

^* To whom correspondence should be addressed. E-mail: abenigni{at}marionegri.it.

Related Article:

Blood Pressure–Independent Reduction in Proteinuria and Arterial Stiffness After Acute Endothelin-A Receptor Antagonism in Chronic Kidney Disease

Neeraj Dhaun, Iain M. MacIntyre, Vanessa Melville, Pajaree Lilitkarntakul, Neil R. Johnston, Jane Goddard, and David J. Webb
Hypertension 2009 54: 113-119. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				N. Dhaun, I. M. MacIntyre, V. Melville, P. Lilitkarntakul, N. R. Johnston, J. Goddard, and D. J. Webb Effects of Endothelin Receptor Antagonism Relate to the Degree of Renin-Angiotensin System Blockade in Chronic Proteinuric Kidney Disease Hypertension, September 1, 2009; 54(3): e19 - e20. [Full Text] [PDF]